The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors
Hannah C. Timmins, Tiffany Li, David Goldstein, Terry Trinh, David Mizrahi, Michelle Harrison, Lisa G. Horvath, Michael Friedländer, Matthew C. Kiernan, Susanna B. Park
Topics & Concepts
MedicineInternal medicineOverweightChemotherapy-induced peripheral neuropathyCancerTolerabilityComorbidityBody mass indexPhysical therapyPeripheral neuropathyDiabetes mellitusAdverse effectEndocrinologyCancer Treatment and PharmacologyChemotherapy-induced cardiotoxicity and mitigationCancer Risks and Factors